Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000899140-10-000528
Filing Date
2010-06-16
Accepted
2010-06-16 16:33:39
Documents
3
Group Members
CHARLES R. KAYEJOSEPH P. LANDYWARBURG PINCUS & CO.WARBURG PINCUS LLCWARBURG PINCUS PARTNERS, LLCWARBURG PINCUS X LLCWARBURG PINCUS X PARTNERS, L.P.WARBURG PINCUS X, L.P.

Document Format Files

Seq Description Document Type Size
1 INITIAL FILING h5663173a.htm SC 13D 414605
2 JOINT FILING AGREEMENT h5663177b.htm EX-1 48585
3 VOTING AGREEMENT h5663177c.htm EX-5 81257
  Complete submission text file 0000899140-10-000528.txt   546822
Mailing Address 7000 SHORELINE COURT SUITE 370 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 370 SOUTH SAN FRANCISCO CA 94080 6505886404
Hana Biosciences Inc (Subject) CIK: 0001140028 (see all company filings)

EIN.: 841588441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-79910 | Film No.: 10900927
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WARBURG PINCUS LLC 466 LEXINGTON AVENUE NEW YORK NY 10017
Business Address C/O WARBURG PINCUS LLC 466 LEXINGTON AVENUE NEW YORK NY 10017 212-878-0600
Warburg Pincus Private Equity X, L.P. (Filed by) CIK: 0001414565 (see all company filings)

EIN.: 200849130
Type: SC 13D